US10576154 — Semifluorinated alkane compositions
Method of Use · Assigned to Novaliq GmbH · Expires 2035-10-01 · 9y remaining
What this patent protects
This patent protects novel compositions of semifluorinated alkanes used as medicines for topical administration to an eye or ophthalmic tissue.
USPTO Abstract
The invention provides novel compositions comprising semifluorinated alkanes and at least one compound sensitive or prone to oxidation. The compositions can be used as medicines that are topically administered to an eye or ophthalmic tissue. The invention further provides kits comprising such compositions.
Drugs covered by this patent
- Miebo (PERFLUOROHEXYLOCTANE) · Bausch Health
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1900 |
— | Miebo |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.